Objective-To study atherosclerosis regression in mice after plasma lipid reduction to moderately elevated apolipoprotein B (apoB)-lipoprotein levels. Approach and Results-Chow-fed hypomorphic Apoe mice deficient in low-density lipoprotein receptor expression (Apoe h/h Ldlr -/-Mx1-cre mice) develop hyperlipidemia and atherosclerosis. These mice were studied before and after inducible cre-mediated Apoe gene repair. By 1 week, induced mice displayed a 2-fold reduction in plasma cholesterol and triglyceride levels and a decrease in the non-high-density lipoprotein:high-density lipoprotein-cholesterol ratio from 87%:13% to 60%:40%. This halted atherosclerotic lesion growth and promoted macrophage loss and accumulation of thick collagen fibers for up to 8 weeks. Concomitantly, blood Ly-6C high monocytes were decreased by 2-fold but lesional macrophage apoptosis was unchanged. The expression of several genes involved in extracellular matrix remodeling and cell migration was changed in lesional macrophages 1 week after Apoe gene repair. However, mRNA levels of numerous genes involved in cholesterol efflux and inflammation were not significantly changed at this time point.
A therosclerosis-related cardiovascular disease remains a leading cause of death worldwide. 1 Atherosclerotic lesions develop in part from the infiltration of circulating monocyte-derived macrophages within the arterial intima in response to an accumulation of apolipoprotein B (apoB)containing lipoproteins secondary to hyperlipidemia. 2 Advanced and unstable lesions can rupture causing thrombosis, acute cardiovascular events, and death. 2 Thus, plaque stabilization and regression are important therapeutic goals. Promising results were recently obtained with intensive lipidlowering therapies using high doses of statins in humans. 3 Although lesion remodeling was observed in these clinical trials, plaque shrinkage and prevention of cardiovascular events remained modest. 3 The search for new treatments to promote atherosclerosis regression in humans has led to the development of mouse models in which cellular and molecular mechanisms can be more readily investigated. Plaque regression and stabilization, characterized mainly by a reduction in macrophage content and the accumulation of collagen, have been achieved in mouse models of atherosclerosis in which interventions exerted a drastic and lasting reduction of diet-induced hypercholesterolemia. 4 Because mice respond poorly to the cholesterol-lowering effect of statins, 4 multiple strategies, ranging from aortic arch transplant 5 to transgene induction [6] [7] [8] [9] [10] [11] often performed in combination with diet change, have been developed to trigger significant plasma lipid lowering. Studies of some of these models showed that during plaque remodeling, lesional macrophages displayed increased expression of genes associated with cholesterol efflux and anti-inflammatory pathways. 10, 12, 13 It was also shown that macrophages egressed from lesions by a C-C chemokine receptor type 7 (CCR7)-dependent mechanism. 10, 12, 14 However, in another study using a different mouse model, 15 reduced macrophage content during plaque regression resulted from decreased monocyte recruitment, not from their egress. Such discordant results highlight the challenge of determining whether these findings are applicable to a general process that would be expected to occur in humans. Thus, investigating mechanisms of plaque regression in alternative mouse models is important to clarify the steps of this clinically relevant process.
Most studies of atherosclerosis regression have investigated the process in the context of plasmas containing high levels of high-density lipoproteins (HDLs) and very low levels of plasma apoB lipoproteins (or non-HDL lipoproteins). 4 In this study, we sought to develop a mouse model in which hyperlipidemia could be reduced to moderately elevated levels of plasma apoB lipoproteins. To achieve this goal, we made use of our previously described hypomorphic ApoE mice (Apoe h/h Mx1-cre) also referred to as HypoE mice. 16 The hypomorphic Apoe allele results in low apoE expression levels (5%-10% of wild-type levels). 16 HypoE mice fed a chow diet display a lipoprotein profile dominated by HDLs similar to wild-type mice. However, HypoE mice are susceptible to diet-induced hyperlipidemia and atherosclerosis that can be reversed by switching them to a chow diet alone and by inducible cre-mediated repair of the hypomorphic Apoe allele. 8, 16 More recently, we have reported that HypoE mice deficient in low-density lipoprotein (LDL) receptor (Apoe h/h Ldlr −/− Mx1cre mice) develop spontaneous hyperlipidemia and atherosclerosis on a chow diet. 17 Here, we show that the inducible cre-mediated repair of the hypomorphic Apoe allele in Apoe h/h Ldlr -/-Mx1-cre mice restored liver apoE expression and caused a reduction in plasma cholesterol and triglyceride levels, characterized by moderately elevated levels of apoB lipoprotein and a humanlike ratio of non-HDL:HDL-cholesterol. 18 These plasma lipid changes occurred in mice which were fed a chow diet throughout the entire study, allowing us to study atheroma remodeling in the absence of potential confounding effects because of feeding or withdrawal of a high-fat diet.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Inducible Repair of the Hypomorphic Apoe Allele in Apoe h/h Ldlr -/-Mx1-cre Mice Restores Hepatic apoE Expression, Reduces Hyperlipidemia, and Improves the Ratio of Non-HDL:HDL-cholesterol
By 20 weeks of age, chow-fed Apoe h/h Ldlr -/-Mx1-cre mice displayed severe hypercholesterolemia and hypertriglyceridemia (719±28 and 390±28 mg/dL respectively, at baseline; Figure 1A and 1B). Inducible repair of the hypomorphic Apoe allele in these mice was induced by 2 intraperitoneal injections of polyinosinic-polycytidylic ribonucleic acid (pIpC) 1 day apart. One week after pIpC treatment, Apoe mRNA expression levels increased by 5-fold in the liver, whereas they were not changed after saline injections ( Figure 2B ). Although apoE immunoreactivity was mainly detected in hepatic sinusoids at baseline, hepatocytes displayed increased intracellular staining after pIpC injections (Figure 2A ), indicating that pIpC treatment effectively repaired the hypomorphic Apoe allele in Apoe h/h Ldlr -/-Mx1-cre mice.
One week after pIpC treatment, both total plasma cholesterol and triglyceride levels were decreased by 2.1-fold to 337±27 and 182±15 mg/dL, respectively ( Figure 1A and 1B). Plasma lipid lowering persisted to the 4-week time point in pIpC-treated mice, whereas no change was observed in control saline-treated mice ( Figure 1A and 1B). The reduction of plasma lipid levels observed after repair of the hypomorphic Apoe allele was associated with significant changes in lipoprotein levels and composition. One week after injection, pIpC-treated mice displayed a 3.8fold decrease in apoB lipoprotein-cholesterol levels ( Table  I in the online-only Data Supplement). Specifically, levels of very-low density lipoprotein (VLDL)-and intermediate density lipoprotein/LDL-cholesterol were reduced by 5.7and 2.6-fold, respectively ( Figure 1D ; Table I in the onlineonly Data Supplement). In addition, plasma apoB48 and apoB100 levels were reduced by 3.7-and 1.2-fold, respectively ( Figure 1C ). Concomitantly, pIpC-induced mice showed an increase in plasma HDL-cholesterol and apoA1 levels by 1.4-and 1.6-fold, respectively ( Figure 1D and 1C; Table I in the online-only Data Supplement). Although we observed a change in the distribution of apoE among plasma lipoproteins before and after intervention, total plasma apoE levels in plasma remained unchanged ( Figures 1C, 2C , and 2D). The repair of the hypomorphic Apoe allele was characterized by an enrichment of apoE in large HDLs that eluted in fractions 18 to 20 after fast protein liquid chromatography ( Figure 2C ) and were found within the 1.02-to 1.06-g/mL lipoprotein density fraction after density ultracentrifugation ( Figure 2D ). Overall, within 1 week of pIpC treatment the drop in cholesterol among apoB lipoproteins and rise among HDLs led to a decrease of the non-HDL:HDL-cholesterol ratio from 7 (87%:13%) to 1.5 (60%:40%; Table I in the online-only Data Supplement; Figure 1 ). These changes in plasma lipids and lipoprotein levels persisted 4 weeks after pIpC treatment, and were independent of any change in body weight or blood glucose level ( Figure III in the onlineonly Data Supplement) and occurred in mice continously fed a chow diet.
Apoe Gene Repair Halts Atherosclerosis Progression in Apoe h/h Ldlr -/-Mx1-cre Mice
Twenty-week-old mice displayed aortic root atherosclerosis that was mainly composed of multi-layered foam cells along with occasional collagen fibrous caps. By 27 weeks of age, atherosclerotic lesions had doubled in size ( Figure 3A and 3C) and atheromas were more advanced, containing thicker layers of macrophages with an increased proportion of smooth muscle cells and fibrous caps ( Figures 3C  and 4C ). Because lesion stage can influence the susceptibility of atheroma remodeling, we examined changes in both 20-and 27-week-old baseline mice, bearing features of early and advanced lesions, respectively. Aortic root lesion sizes were determined in separate groups of mice euthanized either at the baseline time points (20-or 27-week old) or several weeks after pIpC injections. Measurements of lesion size from a parallel group of mice injected with saline were included as a control for lesion progression. As shown in Figure 3A and 3C, saline treatment resulted in increased aortic root lesion area compared with baseline levels (+60% and +90% for the 20-and 27-week-old groups respectively). However, lesion areas of pIpC-treated mice were similar in size at all time points compared with their respective baseline levels ( Figure 3A and 3C) indicating that atherosclerosis progression had been halted. To address whether lesion sizes decreased after a longer period, 20-week-old mice were followed for up to 8 weeks after intervention. Lesion sizes were not different from baseline ( Figure To further characterize atherosclerotic lesions, aortic arches were excised from 20-week-old mice before and 4 weeks after treatment. Aortic lipids were extracted and quantified. Although the content of cholesterol esters and free cholesterol tended to increase in aortic arches of saline-treated mice (P=0.09), there was no change in pIpC-treated mice compared with baseline levels ( Figure 3D ). Overall, these results indicate that repairing the hypomorphic Apoe allele in Apoe h/h Ldlr -/-Mx1-cre mice halted atherosclerosis progression in the aortic arch and aortic root but did not lead to plaque regression or an overall loss of arterial lipids.
Apoe Gene Repair Leads to Macrophage Removal and Accumulation of Thick Collagen Fibers in Atheroma of Apoe h/h Ldlr -/-Mx1-cre Mice
We next investigated lesion composition. As shown in Figure 4A and 4C, the content of MOMA-2-positive macrophages in atheroma was significantly reduced 4 weeks after pIpC injection compared with baseline (−18% and −37% for the 20-and 27-week-old groups, respectively), whereas no change was observed in atheroma of salinetreated mice. The loss in lesional macrophages was accompanied by a marked increase in collagen content (+70% and +75% for the 20-and 27-week-old groups, respectively; Figure 4B ). Lesional macrophage loss and collagen accumulation persisted for up to 8 weeks after Apoe gene repair in 20-week-old mice and in fact was accentuated at this time point (−32% and +135%, respectively; Figure IVC , D, and F in the online-only Data Supplement; Table IV in the online-only Data Supplement). Collagen content was also increased in lesions of saline-treated mice (+48% and +59% for the 20-and 27-week-old groups, respectively; Figure  4B ). However, atheromas of pIpC-and saline-treated mice clearly differed in their relative proportion of intimal collagen and macrophages with a higher ratio of collagen to macrophages in pIpC-treated mice compared with saline control mice (1.7-fold; P=0.06 and 1.7-fold; P=0.05 for 20-and 27-week-old groups, respectively). The distribution and type of collagen that accumulated also differed between pIpC-and saline-treated mice ( Figure 4C ; Figure  VI in the online-only Data Supplement). Lesions of pIpCtreated mice were characterized by densily packed, thick, and strongly birefringent yellow-red type I collagen fibers within macrophage-depleted area that are recognized for their rigidity. 19 In contrast, lesions of saline control mice contained more diffuse networks of green type III collagen fibers surrounding foam cells, known for their extensibility. 19 The proportion of type I to type III collagen was quantitatively increased in lesions of pIpC-treated mice compared with those of saline control mice in the 27-weekold group ( Figure VIB 
Apoe Gene Repair Does Not Impact Lesional Macrophage Apoptosis in Apoe h/h Ldlr -/-Mx1-cre Mice
To address whether increased macrophage apoptosis contributed to plaque macrophage loss, we quantified cells positive for MOMA-2, Hoescht, and TUNEL ( Figure 5A ) in lesions of mice at baseline and 4 weeks after pIpC or saline treatment in both 20-and 27-week-old cohorts. Apoptotic macrophages were observed within lesions of all groups at an expected low frequency ( Figure 5B ). As shown in Figure 5C , the frequency of apoptotic macrophages (calculated by the number of apoptotic macrophage per square millimeter of MOMA-2 area) was unchanged between baseline and pIpC-injected mice in both 20-and 27-week-old cohorts.
ApoE-Dependent Plasma Lipid Lowering in Apoe h/h Ldlr -/-Mx1-cre Mice Changes Gene Expression in Lesional Macrophages
Prior studies of murine models of plasma lipid lowering and atheroma remodeling identified changes in the expression of genes involved in cholesterol efflux, macrophage polarity (M1/M2), and egress from lesion. 10, 12, 13 To gain insight into the processes that led to lesion remodeling and macrophage loss in our model, we investigated molecular changes in macrophages isolated by laser capture microdissection from aortic root lesions. Lesional macrophages at baseline were compared with those isolated 1 week after treatment. No significant changes were observed in mRNA levels of genes related to cholesterol efflux (Lxrα, Lxrβ, Abca1, Abcg1; Figure 5D ), M1 inflammatory (Tnfα, Mcp1), or M2 anti-inflammatory responses (Mgl1, Tgfβ; Figure 5E ). In addition, the expression of Ccr7, previously implicated in macrophage egress during plaque remodeling, 13 showed a trend for an increase (P=0.27) but was not significantly changed at the mRNA level at this time point ( Figure 5E ).
To further investigate possible changes in gene expression in lesional macrophages, we used a real-time polymerase chain reaction array containing ≈600 genes related to cardiovascular diseases (OpenArray, Inc). We identified 23 genes that displayed significantly altered mRNA levels 1 week after treatment ( Figure 5F ; Table II in the online-only Data Supplement). Among these, several genes were associated with extracellular matrix remodeling and cell migration, including matrix metalloproteinase-2 and -19 (Mmp2 by 0.6fold, Mmp19 by 4.1-fold), cell adhesion regulator (Spg7 by 2.2-fold), chondroitin sulfate proteoglycan 2/Versican (Vcan by 1.6-fold), and integrin-β2 (Itgb2 by 1.27-fold; Figure  5F ; Table II in the online-only Data Supplement). Of note, mRNA expression levels of proapoptotic (Bax, Caspase-3 and 6) and antiapoptotic (Bcl2 and Bcl-xL) genes, present on the OpenArray, were unchanged 1 week after lipid lowering ( Table III in 
Apoe Gene Repair Decreases Blood Ly-6C high Monocytes in Apoe h/h Ldlr -/-Mx1-cre Mice
Because blood monocyte recruitment into plaques is strongly affected by monocyte levels in the circulation, 20 we examined whether restoration of apoE expression affected blood monocyte levels in the 27-week-old group of mice. As shown in Figure 6A , a 30% decrease in the number of total circulating monocytes was observed 2 weeks after pIpC-induced Apoe reexpression, whereas there was no reduction in saline-treated mice. The reduction in blood monocytes derived mainly from a 64% decrease in the number of Ly-6C high monocyte subsets ( Figure 6B ), whereas the number of Ly-6C low monocytes did not change significantly ( Figure 6C ). There was no detectable change in the numbers of Ly-6C high and Ly-6C low monocyte subsets in the saline-treated mice ( Figure 6B and 6C ).
Discussion
Plaque stabilization and regression are important therapeutic goals to prevent atherosclerosis-related cardiovascular disease. However, the underlying cellular and molecular mechanisms that govern these processes remain incompletely understood. In the present study, we studied a mouse model of reversible hyperlipidemia, in which atheroma remodeling occurs in the context of mildly elevated plasma apoB lipoprotein levels and a human-like ratio of non-HDL:HDL-cholesterol. Apoe h/h Ldlr -/-Mx1-cre mice develop spontaneous hyperlipidemia and atherosclerosis on a chow diet. 17 Here, we show that the inducible repair of the hypomorphic Apoe alleles in these mice caused (1) plasma lipid reduction characterized by a decrease of the non-HDL:HDL-cholesterol ratio from 7 to 1.5;
(2) arrest of atherosclerosis progression; (3) progressive loss of lesional macrophages and accumulation of thick collagen fibers, hallmarks of plaque stabilization; (4) unchanged frequency of apoptotic lesional macrophages; (5) changes in the expression of genes involved in extracellular matrix remodeling and cell migration in lesional macrophages; (6) no significant changes in the expression of Ccr7 and genes involved in cholesterol efflux and inflammation in lesional macrophages 1 week after plasma lipid lowering; and (7) decreased numbers of circulating Ly-6C high monocytes.
First, we observed that restoring normal apoE expression in chow-fed Apoe h/h Ldlr -/-Mx1-cre mice rapidly decreased plasma lipids and apoB lipoprotein levels, consistent with the notion that hepatic apoE production is required for the clearance of remnant lipoproteins in the absence of the LDL receptor. 21 Inducible Apoe gene repair in these mice also led to a rise in plasma HDL-cholesterol and apoA1 levels accompanied by enrichment in large apoE-rich HDLs supporting the proposed role of apoE in promoting HDL expansion and remodeling. 22 The resulting non-HDL:HDL-cholesterol ratio decreased from 7 (87%:13%) to 1.5 (60%:40%). These values differed from many other mouse models of atherosclerosis regression and remodeling 4 as they remained within the range of a lipoprotein ratio seen in humans. 18 In this model, we showed that atherosclerosis progression was halted and that atheroma adopted features of stabilization for up to 8 weeks after Apoe gene repair. However, there was no evidence of lesion regression. Several studies in humans 3 and mice 5, 6, 9, 11 including our prior studies of HypoE mice 8 suggested that a drastic reduction in circulating apoB lipoproteins was a key permissive component for lesion regression. Thus, it is possible that levels of apoB lipoprotein remained too high in our model (≈200 mg/dL) for lesion regression to occur. Of interest, lesion regression was not observed in other mouse models that display drastic reductions of apoB lipoprotein levels such as in the Reversa mouse 10 or in Ldlr -/mice switched from a high-fat diet to a chow diet. 9, 23 Conversely, lesion regression was reported in mice, despite very high level of non-HDL-cholesterol levels. 7, 24 Thus, taken together, our study and those of others suggest that lesion regression is influenced by several diverse parameters and not solely by reductions of plasma lipid levels.
Further, we showed that Apoe gene repair induced lesion stabilization as evidenced by an accumulation of thick collagen fibers and macrophage loss. Atheroma stabilization was reported in mice with high plasma apoB lipoproteins in which HDL levels were elevated by apoA1 overexpression. 11, 25, 26 Thus, the increase in HDL particles observed after Apoe gene repair likely contributed to lesion remodeling in our model. Changes in plaque composition occurred without a change in neutral lipid content as assessed by oil red O staining. The amount of cholesterol esters and free cholesterol in the aortic arch was also quantitatively unchanged after intervention. Consistent with our findings of no net lipid loss from atheroma, we did not detect changes in the expression of genes involved in cholesterol efflux (Lxrα, Lxrβ, Abca1, and Abcg1) in lesional macrophages 1 week after lipid lowering. Overall, our results indicate that lesional macrophage loss can occur independently of net arterial lipid loss and of increased cholesterol efflux capacity. Van Craeyveld et al 11 recently reported plaque remodeling with a reduction in macrophage content without net neutral lipid loss in Ldlr -/mice after LDL receptor transgene induction. This is in contrast with other studies reporting that macrophage loss occurred concurrently 5, 6, 10 or preceded 15 arterial neutral lipid loss and was associated with increased expression of genes involved in cholesterol efflux. 12 In the latter studies, hyperlipidemia lowering was triggered by diet change 10, 12 or by virus-derived apoE expression in Apoe −/− mice. 6, 15 Thus, it is possible that the withdrawal of diets rich in fat or an overexpression of apoE itself rapidly induced the removal of arterial lipids independently of an effect on lesional macrophage loss.
Levels of monocytes in the circulation strongly affect the rate of their infiltration in the vessel wall where they transform into plaque macrophages. 20 We found that the Ly-6C high monocyte subset was reduced after Apoe gene repair. Ly-6C high monocytes are known to preferentially accumulate in growing atheroma in hyperlipidemic mice. 27 The frequency of apoptotic lesional macrophages was unchanged after apoE restoration. So, it is possible that decreased Ly-6C high monocyte recruitment, coupled with a stable rate of macrophage apoptosis, led to reduced lesional macrophage content in our model. Interestingly, Murphy et al 28 recently demonstrated that cell-derived apoE inhibits hematopoietic stem cell proliferation and monocytosis in hyperlipidemic mice. Thus, the inducible cre-mediated repair of the hypomorphic Apoe allele in Apoe h/h Ldlr -/-Mx1-cre mice may have affected hematopoietic stem cell proliferation and monocytosis. The potential importance of blood monocytes in modulating lesional macrophage loss during plaque remodeling was highlighted in 2 recent studies. 15, 23 First, a decrease in blood monocyte levels was observed in Ldlr -/mice fed an atherogenic diet followed by a switch to a low-fat diet. 23 Second, Potteaux et al 15 recently demonstrated that suppressed monocyte activation and recruitment coupled with a stable rate of apoptosis accounted for macrophage loss in regressing lesions of high-fat diet-fed Apoe −/− mice treated with apoE-encoding adenoviral vectors. Monocytosis is an independent risk factor for atherosclerosis progression in humans. 29 Thus, our findings and those of others underscore the potential impact of modulating circulating monocyte levels, phenotypes, and recruitment to achieve atheroma remodeling.
Loss of macrophages from lesions could also result from their egress. Several studies of the aortic arch transplant model 12, 14 and the Reversa mouse 10 showed that macrophage emigration to regional and systemic lymph nodes participated in their removal during lesion regression and remodeling. This process relied on liver X receptor-dependent upregulation of the chemokine receptor CCR7 in macrophages which confers dendritic cell-like features. 30 Van Craeyveld et al 11 recently failed to detect increased Ccr7 expression during plaque remodeling in Ldlr -/mice 12 weeks after LDL receptor transgene induction. However, in that study, gene expression was assessed in whole lesions from aortic roots and brachiocephalic arteries, not specifically in lesional macrophages. In our study, mRNA levels of Lxrα and Ccr7 were not significantly changed in lesional macrophages 1 week after Apoe gene repair. Nevertheless, Ccr7 expression might have been differently expressed at an earlier or later time point as previously observed in studies of the aortic arch transplant model and the Reversa mouse, 3 or 14 days after lipoprotein profile correction, respectively. 10, 12 Other factors could also account for the differences between our results and earlier studies. 10, 12 The lesion stage at which the intervention was applied or the withdrawal of the atherogenic diet to induce lipid lowering may both have influenced lesional gene expression independently of lipid lowering. Potteaux et al 15 recently demonstrated that lesional macrophage loss during lesion remodeling was independent of a role of CCR7-induced egress in the high-fat diet-fed Apoe −/− mouse after apoE was reintroduced by liver-directed gene transfer. Collectively, these observations suggest that plaque macrophage loss could occur independently of the upregulation of the CCR7 pathway in some mouse models and not in others. Additional studies will be required to conclude on the role of CCR7-dependent or independent egress in our model.
Atherosclerotic lesions ultimately progress toward unstable phenotypes characterized by the upregulation of matrix metalloproteinases, such as Mmp2, involved in the breakdown of collagen. 31 Interestingly, in our model, the expression of Mmp2 was decreased in lesional macrophages 1 week after August 2013 Apoe gene repair, supporting the concept that lesional macrophages undergo an active genetic reprogramming that likely contributes to collagen accumulation and lesion stabilization. Increases in the expression of genes involved in cell mobility, such as Mmp19 32 or Vasp, 33 or cell adhesion, such as Vcan 34 or Itgb2, were also observed after treatment, suggesting that residual macrophages participate in a dynamic restructuration of the lesion that could involve cellular migration within or out of atheroma. Future studies will explore in more detail the role of individual candidate genes in atherosclerosis remodeling.
In conclusion, the inducible repair of the hypomorphic Apoe allele in chow-fed Apoe h/h Ldlr -/-Mx1-cre mice resulted in plasma lipid lowering with mildly elevated apoB lipoproteins and a human-like ratio of non-HDL:HDL-cholesterol. These changes led to stabilization of atherosclerotic lesions, characterized by macrophage loss and accumulation of thick collagen fibers. Our data support that plaque macrophage loss during lesion stabilization and remodeling derives in part from reduced blood Ly-6C high monocyte levels and genetic reprogramming of lesional macrophages.
